All Posts:Lewy body dementia
-
Georgetown Offers Multiple Clinical Trials for People with Lewy Body Dementia
WASHINGTON (October 8, 2019) — Georgetown University Medical Center, a Lewy Body Dementia (LBD) Association Research Center of Excellence, is now offering three clinical trials to study new treatments for LBD, a disease often confused with Parkinson’s and Alzheimer’s disease. Lewy body dementia has similar symptoms to both Parkinson’s and Alzheimer’s diseases — some people […]
Category: News Release
-
Shedding Light on Lewy Body Disease
(May 30, 2019) — Though many people are familiar with Parkinson’s and Alzheimer’s diseases, fewer have heard of Lewy body dementia, a neurodegenerative disorder with similar symptoms. “I think more awareness needs to be out there because Lewy body disease is probably just as prevalent as Parkinson’s,” said Fernando Pagan, MD (M’96), professor of neurology […]
Category: GUMC Stories
-
Georgetown University Launches Clinical Trial for Lewy Body Dementia
MEDIA CONTACT:(for members of the press only) Karen Teberkm463@georgetown.edu PATIENT INFORMATION:Joy Arellanomja6@gunet.georgetown.edu WASHINGTON (May 30, 2019) — Georgetown University Medical Center announces the launch of the only known therapeutic (disease modifying) clinical trial for Lewy body dementia, a neurological disorder that affects a million people in the United States for which there are no approved […]
Category: News Release
-
Researchers Find Inhibiting One Protein Destroys Toxic Clumps Seen in Parkinson’s Disease
MEDIA CONTACT (ONLY, PLEASE):Karen Teberkm463@georgetown.edu WASHINGTON (November 14, 2018) — A defining feature of Parkinson’s disease is the clumps of alpha-synuclein protein that accumulate in the brain’s motor control area, destroying dopamine-producing neurons. Natural processes can’t clear these clusters, known as Lewy bodies, and no one has demonstrated how to stop the build up as well […]
Category: News Release
-
Georgetown University Medical Center Selected as Lewy Body Dementia Research Center of Excellence
The Lewy Body Dementia Association has designated Georgetown University Medical Center as a “Research Center of Excellence.” GUMC joins 23 other centers chosen for their clinical expertise in Lewy body dementia, experience running clinical trials in related conditions, their facility’s capacity and willingness to participate, and their geographic locations.
Category: News Release
-
Researchers Report First Therapy Appearing to Reverse Decline in Parkinson’s
OCTOBER 17, 2015 – An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC). The drug, nilotinib (known as Tasigna® by Novartis) also led to statistically significant and encouraging changes in toxic […]
Category: GUMC Stories
-
Cancer Drug Improved Cognition and Motor Skills in Small Parkinson’s Clinical Trial
CHICAGO (Oct. 17, 2015) — An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small phase I clinical trial, report researchers at Georgetown University Medical Center (GUMC) in Washington. In addition, the drug, nilotinib (Tasigna® by Novartis), led to statistically significant […]
Category: News Release
-
Cancer Drug Prevents Build-up of Toxic Brain Protein
WASHINGTON (May 10, 2013) — Researchers at Georgetown University Medical Center have used tiny doses of a leukemia drug to halt accumulation of toxic proteins linked to Parkinson’s disease in the brains of mice. This finding provides the basis to plan a clinical trial in humans to study the effects. They say their study, published […]
Category: News Release